No valuation for ElevateBio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($926.0M) and the funding record below are the closest available signals.
- ·36 fund marks: filer, period, implied $/share
Membership and data by Private Market View
ElevateBio funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2023 | Later Stage VC (Series D) | $401.0M | ▮ | ▮ |
| Jan 2021 | Later Stage VC (Series C) | $525.0M | ▮ | ▮ |
Membership and data by Private Market View
Recent activity
In the last 90 days, ElevateBio's record added 1 institutional fund mark (latest period Jul 2026).
How much has ElevateBio raised?
ElevateBio has raised $926 million across 2 recorded rounds since 2021. The largest was a $525 million Series C in Jan 2021; the most recent was a $401 million Series D in May 2023.
Institutional holders and vehicles
4 SEC-registered funds reported 36 fair-value marks on ElevateBio between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How ElevateBio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ElevateBio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about ElevateBio
- How much has ElevateBio raised?
- ElevateBio has raised $926.0M in total funding across 2 recorded rounds.
- When did ElevateBio last raise?
- ElevateBio last raised in May 2023 (Later Stage VC (Series D)), raising $401.0M.